Measurements of CXCL16 and CXCL17 strengthen the prognostic value of LGR5 by detecting high number of aggressive tumor cells and/or tumor growth promoting cells in the tumor cell microenvironment, as discussed earlier [17,18]. The gene discussed is CXCL17; the disease is neoplasm.